Illumina (NASDAQ:ILMN) reported quarterly earnings results on February 05, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $1.35, beating the consensus estimate of $1.25 by $0.10 per share. Revenue came in at $1.2B, beating the estimate of $1.1B.
Illumina's stock moved following the earnings release. The stock currently trades at $121.87 with a market capitalization of $20.8B.


